Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
30.0%
% of HRTS's 41 holdings also in AGNG
14.8%
% of AGNG's 81 holdings also in HRTS
Overlap by Weight
Sector Drift (HRTS minus AGNG)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS | Weight in AGNG | Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.1% | 3.1% | 3.1% |
|
BOSTON SCIENTIFIC CORP | 3.0% | 4.1% | 3.0% |
 |
MEDTRONIC PLC | 3.0% | 3.0% | 3.0% |
|
BRISTOL-MYERS SQUIBB CO | 2.6% | 3.4% | 2.6% |
|
ABBVIE INC | 2.4% | 3.4% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to AGNG
|
ELI LILLY & CO | 7.0% |
|
UNITEDHEALTH GROUP INC | 6.0% |
|
BRIDGEBIO PHARMA, INC. | 4.2% |
 |
ASTRAZENECA PLC | 4.1% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 3.9% |
|
ABBOTT LABORATORIES | 3.8% |
|
VERTEX PHARMACEUTICALS INC | 3.4% |
|
GILEAD SCIENCES INC | 3.1% |
|
THERMO FISHER SCIENTIFIC INC | 3.1% |
|
NOVARTIS AG | 2.9% |
HRTS Underweight Relative to AGNG
|
WELLTOWER, INC. | -4.8% |
|
ALCON, INC. | -3.3% |
|
ROCHE HOLDING AG-BR | -3.2% |
|
JOHNSON & JOHNSON | -3.1% |
|
ASTRAZENECA PLC-SPONS ADR | -3.0% |
|
STRYKER CORP | -3.0% |
 |
UCB SA | -3.0% |
 |
TERUMO CORP | -2.4% |
 |
CELLTRION INC | -2.3% |
|
VENTAS INC | -2.3% |